ASRT +.98 6.94 on good guidance and medical group guidance that says their top product Indocin should be used for all cases instead of just acute cases, expanding their market 3x for the product.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.